Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Wiegand

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Swiss Medical Weekly|August 21, 2007
Does a negative D-dimer test rule out aortic dissection?Jan Wiegand, Michael Koller, Roland Bingisser
International Journal of Radiation Biology|April 29, 2009
Desferrithiocin analogue uranium decorporation agentsRaymond J Bergeron, Jan Wiegand, Shailendra Singh
Acta Neurochirurgica|January 27, 2016
Indicators of external ventricular drainage-related infections--a retrospective observational studyJan Wiegand, Liz Hickson, Tobias M Merz
Blood|April 4, 2002
HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoningRaymond J Bergeron, Jan Wiegand, Gary M Brittenham
Journal of Medicinal Chemistry|September 11, 2014
Desferrithiocin: a search for clinically effective iron chelatorsRaymond J Bergeron, Jan Wiegand, James S McManis, et al.
Bioorganic & Medicinal Chemistry|August 2, 2015
Metabolically programmed iron chelatorsRaymond J Bergeron, Neelam Bharti, James S McManis, et al.
Journal of Medicinal Chemistry|August 15, 2012
Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profilesRaymond J Bergeron, Jan Wiegand, Neelam Bharti, et al.
Journal of Medicinal Chemistry|November 28, 2006
The design, synthesis, and evaluation of organ-specific iron chelatorsRaymond J Bergeron, Jan Wiegand, James S McManis, et al.
BMC Bioinformatics|October 3, 2006
Analysis with respect to instrumental variables for the exploration of microarray data structuresFlorent Baty, Michaël Facompré, Jan Wiegand, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|November 25, 2010
Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicityRaymond J Bergeron, Jan Wiegand, Neelam Bharti, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Swiss Medical Weekly|August 21, 2007
Does a negative D-dimer test rule out aortic dissection?Jan Wiegand, Michael Koller, Roland Bingisser
International Journal of Radiation Biology|April 29, 2009
Desferrithiocin analogue uranium decorporation agentsRaymond J Bergeron, Jan Wiegand, Shailendra Singh
Acta Neurochirurgica|January 27, 2016
Indicators of external ventricular drainage-related infections--a retrospective observational studyJan Wiegand, Liz Hickson, Tobias M Merz
Blood|April 4, 2002
HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoningRaymond J Bergeron, Jan Wiegand, Gary M Brittenham
Journal of Medicinal Chemistry|September 11, 2014
Desferrithiocin: a search for clinically effective iron chelatorsRaymond J Bergeron, Jan Wiegand, James S McManis, et al.
Bioorganic & Medicinal Chemistry|August 2, 2015
Metabolically programmed iron chelatorsRaymond J Bergeron, Neelam Bharti, James S McManis, et al.
Journal of Medicinal Chemistry|August 15, 2012
Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profilesRaymond J Bergeron, Jan Wiegand, Neelam Bharti, et al.
Journal of Medicinal Chemistry|November 28, 2006
The design, synthesis, and evaluation of organ-specific iron chelatorsRaymond J Bergeron, Jan Wiegand, James S McManis, et al.
BMC Bioinformatics|October 3, 2006
Analysis with respect to instrumental variables for the exploration of microarray data structuresFlorent Baty, Michaël Facompré, Jan Wiegand, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|November 25, 2010
Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicityRaymond J Bergeron, Jan Wiegand, Neelam Bharti, et al.
Pageof 4